TP53 and cancer: Conversely, the cisplatin‐treated organoids exhibited a marked upregulation of genes within the p53 signaling pathway, suggesting that cisplatin's mechanism of inhibiting cancer cell proliferation is mediated through apoptosis, triggered by the activation of the p53 pathway.